Related Experiment Video
Updated: Aug 11, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation
Xiaoming Dai1, Cong Jiang1, Qiwei Jiang2
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Abstract:
The mechanistic target of rapamycin complex 1 (mTORC1) controls cell growth in response to amino acid and glucose levels. However, how mTORC1 senses glucose availability to regulate various downstream signalling pathways remains largely elusive. Here we report that AMP-activated protein kinase (AMPK)-mediated phosphorylation of WDR24, a core component of the GATOR2 complex, has a role in the glucose-sensing capability of mTORC1. Mechanistically, glucose deprivation activates AMPK, which directly phosphorylates WDR24 on S155, subsequently disrupting the integrity of the GATOR2 complex to suppress mTORC1 activation. Phosphomimetic Wdr24S155D knock-in mice exhibit early embryonic lethality and reduced mTORC1 activity. On the other hand, compared to wild-type littermates, phospho-deficient Wdr24S155A knock-in mice are more resistant to fasting and display elevated mTORC1 activity. Our findings reveal that AMPK-mediated phosphorylation of WDR24 modulates glucose-induced mTORC1 activation, thereby providing a rationale for targeting AMPK-WDR24 signalling to fine-tune mTORC1 activation as a potential therapeutic means to combat human diseases with aberrant activation of mTORC1 signalling including cancer.
Insights
AMP-activated protein kinase (AMPK) phosphorylates WDR24, a GATOR2 component, to regulate how the mechanistic target of rapamycin complex 1 (mTORC1) senses glucose. This discovery offers new therapeutic targets for diseases involving abnormal mTORC1 signaling.
Area of Science:
- Cellular signaling
- Metabolic regulation
- Molecular mechanisms
Background:
- The mechanistic target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth, influenced by nutrient availability.
- The precise mechanisms by which mTORC1 senses glucose levels to control downstream pathways are not fully understood.
Purpose of the Study:
- To elucidate the role of AMP-activated protein kinase (AMPK) in glucose sensing by mTORC1.
- To identify novel components involved in the mTORC1 glucose-sensing pathway.
Main Methods:
- Investigated the phosphorylation of WDR24 by AMPK in response to glucose deprivation.
- Utilized phosphomimetic (S155D) and phospho-deficient (S155A) Wdr24 knock-in mouse models.
- Assessed mTORC1 activity and physiological responses in these models.
Main Results:
- AMPK-mediated phosphorylation of WDR24 on S155 disrupts the GATOR2 complex, suppressing mTORC1 activation during glucose deprivation.
- Wdr24S155D mice showed early embryonic lethality and reduced mTORC1 activity.
- Wdr24S155A mice exhibited enhanced resistance to fasting and elevated mTORC1 activity.
Conclusions:
- AMPK-dependent WDR24 phosphorylation is a critical mediator of glucose-induced mTORC1 activation.
- Targeting the AMPK-WDR24 signaling axis presents a potential therapeutic strategy for diseases characterized by aberrant mTORC1 signaling, such as cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

